Skip to content

Exploratory Study on Medication Understanding and Treatment Satisfaction in Patients Taking New Oral Pain Medications

Exploratory Study on Medication Understanding and Treatment Satisfaction in Patients Taking New Oral Pain Medications - Exploratory Study on Medication Understanding and Treatment Satisfaction in Patients Taking New Oral Pain Medications

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000052629
Enrollment
300
Registered
2023-10-27
Start date
2023-11-06
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

None listed

Sponsors

DAIICHI SANKYO CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients with a history of taking new oral pain medications since April 2023. 2)Patients aged 18 and over at the time of consent. 3)Patients capable of giving consent via electronic methods (Web) based on their own free will for participation in the study. 4)Patients who can appropriately respond to questions in Japanese via electronic methods (Web) without assistance.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Treatment satisfaction

Secondary

MeasureTime frame
Medication understanding Information about medication explanation (This includes explanation content, who provided the explanation, and the medium of the explanation) Information about medication discontinuation (This includes whether the medication was discontinued, reasons for discontinuation, and treatments following discontinuation)

Countries

Japan

Contacts

Public ContactHaruhiko Seki

INTAGE Healthcare Inc. Value & Access Department

haruhiko.seki@intage.com03-5295-1579

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026